Table 4 DXA scan body mass measures.

From: Physical deterioration and adaptive recovery in physically inactive breast cancer patients during adjuvant chemotherapy: a randomised controlled trial

Variable

Group

T0: Mean (SD) (n = 153)

T2: Mean (SD) (n = 128)

T3: Mean (SD) (n = 115)

Delta (95% CI)

p

diff (95% CI)

p

Weight (kg)

1

74.7 (14.3)

74.6 (13.9)

 

−0.1 (−1 to 0.8)

0.8320

−0.4

0.5866

2

73 (13.7)

73.3 (14)

 

0.3 (−0.7 to 1.2)

0.576

(−1.7 to 1.0)

 

1

75.1 (14.7)

 

74 (13.6)

−1.1 (−2.1 to −0.2)

0.0215

−0.6

0.4068

2

72.7 (13)

 

72.1 (13.2)

−0.6 (−1.5 to 0.4)

0.2594

(−2.0 to 0.8)

 

Fat mass (g)

1

29342 (10039)

28169 (9815)

 

−1152 (−2307 to 3)

0.0507

−834 (−2457 to 788)

0.3120

2

28060 (9358)

27767 (9601)

 

−318 (−1457 to 822)

0.5834

  

1

29859 (10179)

 

30269 (11690)

456 (−736 to 1648)

0.4522

795 (−894 to 2484)

0.3548

2

27678 (8754)

 

27353 (8707)

−339 (−1536 to 858)

0.5770

  

Bone mass content (g)

1

2497.2 (346.2)

2492.5 (350.8)

 

−4.2 (−22.8 to 14.5)

0.6608

−13.3

0.3191

2

2407.9 (337.9)

2417.2 (333.2)

 

9.1 (−9.3 to 27.5)

0.3299

(−39.4 to 12.9)

 

1

2482.7 (346.4)

 

2433.1 (335.5)

−48.4 (−67.6 to −29.1)

<0.0001

−12.9

0.3513

2

2412.3 (348.6)

 

2376.5 (344.6)

−35.4 (−54.8 to −16.1)

0.0004

(−40.2 to 14.3)

 

Lean body mass (g)

1

42842 (5218)

43916 (5304)

 

1048 (592 to 1505)

<0.0001

486 (−156 to 1127)

0.1372

2

42545 (5465)

43102 (5710)

 

563 (112 to 1013)

0.0146

  

1

42733 (5380)

 

42722 (5057)

−78 (−549 to 394)

0.7456

82 (−586 to 750)

0.8086

2

42556 (5402)

 

42442 (5398)

−160 (−633 to 314)

0.5064

  

Bone mineral density

1

1.20 (0.12)

1.23 (0.23)

 

0.03 (0.00 to 0.07)

0.0696

0.02 (−0.03 to 0.07)

0.459

2

1.16 (0.19)

1.18 (0.12)

 

0.01 (−0.02 to 0.05)

0.4283

  

1

1.19 (0.11)

 

1.18 (0.11)

−0.01 (−0.04 to 0.03)

0.6288

0.00 (−0.05 to 0.05)

0.9815

2

1.16 (0.19)

 

1.15 (0.12)

−0.01 (−0.04 to 0.03)

0.6066

  

T-score (SD)

1

1.21 (1.19)

1.19 (1.18)

 

−0.02 (−0.08 to 0.05)

0.6585

−0.04 (−0.13 to 0.06)

0.4343

2

0.93 (1.24)

0.95 (1.18)

 

0.02 (−0.04 to 0.09)

0.5056

  

1

1.14 (1.15)

 

0.99 (1.10)

−0.15 (−0.22 to −0.08)

<0.0001

0.03 (−0.07 to 0.13)

0.5395

2

0.86 (1.24)

 

0.69 (1.21)

−0.18 (−0.25 to −0.11)

<0.0001

  
  1. Abbreviations: TO = baseline; T1 = week 6, midway; T2 = week 12, completed; T3 = week 39, follow-up; DXA = dual-energy X-ray absorptiometry; n = maximum n for patients at baseline test and associated follow-up test; 1 = group 1 supervised exercise intervention; 2 = group 2 pedometer exercise intervention; SD = standard deviation; CI = confidence interval.
Back to article page